Yeah, but the whole system is broken. Take what is happening with insulin. Pricing is easily inflated because of 3 primary manufacturers and volume is controlled through large Pharmacy benefit managers (PBMs) and the byzantine rebate structures negotiated -- which actually means that the higher the price, the larger the discount, the more profit returned to PBMs, and manufacturers are incentivized to raise pricing to generate huge rebates to remain on the PBM's formularies --> all of which drives a sub-$5/vial cost to a list price of $400. Depending on which side of the table you are on, it's a legalized kick-back scheme, at worse it's legalized extortion -- in either case, it's needless deaths for the uninsured who don't have access to rebated pricing.
The sad part is I am pro for-profit healthcare, but we've somehow managed to eff it up badly. Hopefully, price/out of pocket transparency is a first step in trying to solve this Gordian knot.
Really good article:
https://fortune.com/longform/insulin-cost-diabetes-treatment/